Acadia Pharmaceuticals Inc. (ACAD)

Last Three Months

19-Feb-22 -- 18-May-22

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

25

0

6

+1

0

+2

0

+3

Two Year Chart

19-May-20 -- 18-May-22

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
03-May-22 8:55 PM View:	02-May-22 Option Sale ($52.09K)	Stankovic Srdjan R. President		Acadia Pharmaceuticals Inc. - ACAD	23% 45.02K to 55.19K	0	0	--	--	Show Txns Hide Txns

03-May-22 8:58 PM View:	02-May-22 Option Sale ($99.69K)	Davis Stephen CEO Director		Acadia Pharmaceuticals Inc. - ACAD	29% 58.72K to 75.88K	0	0	--	--	Show Txns Hide Txns

11-Apr-22 8:02 PM View:	08-Apr-22 Option Sale ($27.73K)	Kihara James Principal Accounting Officer		Acadia Pharmaceuticals Inc. - ACAD	100% 0 to 2.43K	0	0	--	--	Show Txns Hide Txns

03-May-22 8:47 PM View:	02-May-22 Option Sale ($10.04K)	Teehan Brendan EVP, COO, Head of Commercial		Acadia Pharmaceuticals Inc. - ACAD	92% 1.79K to 3.44K	0	0	--	--	Show Txns Hide Txns

03-May-22 8:51 PM View:	02-May-22 Option Sale ($16.25K)	Kim Austin D. EVP,General Counsel, Secretary		Acadia Pharmaceuticals Inc. - ACAD	27% 13.2K to 16.74K	0	0	--	--	Show Txns Hide Txns

25-Feb-22 5:43 PM View:	23-Feb-22 Option Sale ($13.16K)	Schneyer Mark C. EVP, Chief Financial Officer		Acadia Pharmaceuticals Inc. - ACAD	61% 1.3K to 2.1K	0	0	--	--	Show Txns Hide Txns